GlassScriptPhysician profile
Aaron T Arel
NPI 1346773520
$3,171.11
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.46 · 2022: $183 · 2023: $2,224 · 2024: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,940 · Travel and Lodging: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,940.29 |
| Travel and Lodging | $1,026.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $948.13 | 2023 | |
| Abbvie INC. | $510.90 | 2023-2024 | Botox, Ubrelvy, Qulipta |
| Abbott Laboratories | $474.62 | 2023-2024 | Proclaim, Freestyle Libre 3 |
| Pacira Pharmaceuticals Incorporated | $237.03 | 2023-2024 | Iovera, Zilretta |
| Riwospine, INC. | $190.54 | 2023 | Spine |
| Medtronic, INC. | $159.61 | 2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Pfizer INC. | $156.00 | 2023-2024 | |
| Lundbeck LLC | $112.31 | 2024 | Vyepti |
| Relievant Medsystems, INC. | $104.23 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $64.03 | 2022 | |
| Collegium Pharmaceutical, INC. | $57.36 | 2023-2024 | Belbuca |
| Averitas Pharma INC. | $45.35 | 2023 | Qutenza |
| Si-Bone, INC. | $25.66 | 2023 | |
| Novo Nordisk INC | $24.87 | 2023 | Rybelsus, Ozempic |
| Merz Pharmaceuticals, LLC | $24.07 | 2023 | Xeomin |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $21.46 | 2021 | |
| Scilex Pharmaceuticals INC. | $14.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Arel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.